• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期人类免疫缺陷病毒感染

Human immunodeficiency virus infection in pregnancy.

作者信息

Arikan Y, Burdge D R

机构信息

Division of Infectious Diseases;

出版信息

Can J Infect Dis. 1998 Sep;9(5):301-9. doi: 10.1155/1998/274694.

DOI:10.1155/1998/274694
PMID:22346550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3250917/
Abstract

The incidence and prevalence of human immunodeficiency virus (HIV) infection in women of child-bearing age continue to increase both internationally and in Canada. The care of HIV-infected pregnant women is complex, and multiple issues must be addressed, including the current and future health of the woman, minimization of the risk of maternal-infant HIV transmission, and maintenance of the well-being of the fetus and neonate. Vertical transmission of HIV can occur in utero, intrapartum and postpartum, but current evidence suggests that the majority of transmission occurs toward end of term, or during labour and delivery. Several maternal and obstetrical factors influence transmission rates, which can be reduced by optimal medical and obstetrical care. Zidovudine therapy has been demonstrated to reduce maternal-infant transmission significantly, but several issues, including the short and long term safety of antiretrovirals and the optimal use of combination antiretroviral therapy in pregnancy, remain to be defined. It is essential that health care workers providing care to these women fully understand the natural history of HIV disease in pregnancy, the factors that affect vertical transmission and the management issues during pregnancy. Close collaboration among a multidisciplinary team of knowledgeable health professionals and, most importantly, the woman herself can improve both maternal and infant outcomes.

摘要

在国际上以及加拿大,育龄期女性感染人类免疫缺陷病毒(HIV)的发病率和患病率持续上升。对感染HIV的孕妇进行护理十分复杂,必须解决多个问题,包括该女性当前和未来的健康状况、将母婴HIV传播风险降至最低,以及维持胎儿和新生儿的健康。HIV的垂直传播可发生在子宫内、分娩期和产后,但目前的证据表明,大多数传播发生在妊娠晚期,或分娩过程中。一些母体和产科因素会影响传播率,通过最佳的医疗和产科护理可以降低传播率。齐多夫定疗法已被证明可显著降低母婴传播,但包括抗逆转录病毒药物的短期和长期安全性以及孕期联合抗逆转录病毒疗法的最佳使用等几个问题仍有待明确。为这些女性提供护理的医护人员必须充分了解孕期HIV疾病的自然史、影响垂直传播的因素以及孕期的管理问题。由知识渊博的健康专业人员组成的多学科团队,最重要的是女性自身之间的密切合作,可以改善母婴结局。

相似文献

1
Human immunodeficiency virus infection in pregnancy.妊娠期人类免疫缺陷病毒感染
Can J Infect Dis. 1998 Sep;9(5):301-9. doi: 10.1155/1998/274694.
2
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
3
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低母婴传播HIV感染风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2002(1):CD003510. doi: 10.1002/14651858.CD003510.
4
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低母婴传播HIV感染风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2002(2):CD003510. doi: 10.1002/14651858.CD003510.
5
Update on vertical HIV transmission.垂直传播的HIV研究进展。
J Reprod Med. 1998 Aug;43(8):637-46.
6
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
7
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
8
Prevention of perinatal HIV transmission during pregnancy.孕期预防围产期HIV传播。
J Antimicrob Chemother. 2000 Nov;46(5):657-68. doi: 10.1093/jac/46.5.657.
9
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.接受齐多夫定治疗的女性中人类免疫缺陷病毒1型围产期传播的危险因素。儿童艾滋病临床试验组研究185团队。
N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601.
10
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.美国公共卫生服务部特别工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以促进孕产妇健康及采取干预措施减少美国围产期HIV-1传播的建议。
MMWR Recomm Rep. 2002 Nov 22;51(RR-18):1-38; quiz CE1-4.

本文引用的文献

1
A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens.分配到两种预防性抗菌方案的早产儿在死亡率和核黄疸发病率上的差异。
Pediatrics. 1956 Oct;18(4):614-25.
2
Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.美国公共卫生服务工作组关于在感染HIV-1的孕妇中使用抗逆转录病毒药物以保障孕产妇健康和减少围产期HIV-1传播的建议。疾病控制与预防中心。
MMWR Recomm Rep. 1998 Jan 30;47(RR-2):1-30.
3
The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire.科特迪瓦阿比让女性性工作者宫颈阴道HIV脱落、性传播疾病与免疫抑制之间的关联
AIDS. 1997 Oct;11(12):F85-93. doi: 10.1097/00002030-199712000-00001.
4
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.1997年人类免疫缺陷病毒感染的抗逆转录病毒疗法。美国国际艾滋病学会小组的最新建议。
JAMA. 1997 Jun 25;277(24):1962-9.
5
Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.
Nat Med. 1997 May;3(5):549-52. doi: 10.1038/nm0597-549.
6
Update: trends in AIDS incidence, deaths, and prevalence--United States, 1996.最新情况:美国1996年艾滋病发病率、死亡人数及流行趋势
MMWR Morb Mortal Wkly Rep. 1997 Feb 28;46(8):165-73.
7
Obstetric factors and mother-to-infant transmission of HIV-1.
Infect Dis Clin North Am. 1997 Mar;11(1):109-18. doi: 10.1016/s0891-5520(05)70345-7.
8
Vertical HIV-1 transmission correlates with a high maternal viral load at delivery.
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):26-30. doi: 10.1097/00042560-199701010-00005.
9
Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.孕期母体病毒载量与1型人类免疫缺陷病毒母婴传播:法国围产期队列研究。SEROGEST队列研究组。
J Infect Dis. 1997 Jan;175(1):172-5. doi: 10.1093/infdis/175.1.172.
10
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.母亲的病毒载量、齐多夫定治疗与人类免疫缺陷病毒1型母婴传播风险。儿童艾滋病临床试验组方案076研究小组。
N Engl J Med. 1996 Nov 28;335(22):1621-9. doi: 10.1056/NEJM199611283352201.